Trial Outcomes & Findings for Reducing Asthma Morbidity In High Risk Minority Preschool Children (NCT NCT01519453)

NCT ID: NCT01519453

Last Updated: 2021-05-11

Results Overview

The Test for Respiratory and Asthma Control in Kids test is an assessment tool consisting of 5 questions posed to caregivers and designed to assess respiratory and asthma control in patients between 12 months and 5 years. It addresses risk and impairment domains outlined in the Asthma Guidelines and is meant to be interpreted by medical professionals. A total score is calculated from 0-100 with scores less than 80 indicating the child's asthma may not be under control and scores of 80 or more indicating that a child's asthma seems to be under control.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

404 participants

Primary outcome timeframe

Baseline, 3, 6, 9 and 12 months

Results posted on

2021-05-11

Participant Flow

2 refused to complete a baseline assessment after consent 1 participant dropped due to no asthma after consent 3 families were pilot participants and their data is not represented in final outcomes except in sponsor reporting

Participant milestones

Participant milestones
Measure
Home Based Asthma Education Arm
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control Arm
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Overall Study
STARTED
199
199
Overall Study
3 Month
160
181
Overall Study
6 Month
153
175
Overall Study
9 Month
159
166
Overall Study
COMPLETED
147
163
Overall Study
NOT COMPLETED
52
36

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Reducing Asthma Morbidity In High Risk Minority Preschool Children

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Home Based Asthma Education
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Total
n=398 Participants
Total of all reporting groups
Age, Categorical
Child in caregiver-child pair · <=18 years
199 Participants
n=5 Participants
199 Participants
n=7 Participants
398 Participants
n=5 Participants
Age, Categorical
Child in caregiver-child pair · Between 18 and 65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Child in caregiver-child pair · >=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Caregiver in caregiver-child pair · <=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Caregiver in caregiver-child pair · Between 18 and 65 years
199 Participants
n=5 Participants
198 Participants
n=7 Participants
397 Participants
n=5 Participants
Age, Categorical
Caregiver in caregiver-child pair · >=65 years
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Age, Continuous
Child in caregiver-child pair
4.2 years
STANDARD_DEVIATION 0.6 • n=5 Participants
4.2 years
STANDARD_DEVIATION 0.8 • n=7 Participants
4.2 years
STANDARD_DEVIATION 0.7 • n=5 Participants
Age, Continuous
Caregiver in caregiver-child pair
30.9 years
STANDARD_DEVIATION 7.8 • n=5 Participants
31.9 years
STANDARD_DEVIATION 8.9 • n=7 Participants
31.4 years
STANDARD_DEVIATION 8.4 • n=5 Participants
Sex: Female, Male
Child in caregiver-child pair · Female
76 Participants
n=5 Participants
75 Participants
n=7 Participants
151 Participants
n=5 Participants
Sex: Female, Male
Child in caregiver-child pair · Male
123 Participants
n=5 Participants
124 Participants
n=7 Participants
247 Participants
n=5 Participants
Sex: Female, Male
Caregiver in caregiver-child pair · Female
184 Participants
n=5 Participants
187 Participants
n=7 Participants
371 Participants
n=5 Participants
Sex: Female, Male
Caregiver in caregiver-child pair · Male
15 Participants
n=5 Participants
12 Participants
n=7 Participants
27 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Child in caregiver-child pair · Hispanic or Latino
6 Participants
n=5 Participants
8 Participants
n=7 Participants
14 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Child in caregiver-child pair · Not Hispanic or Latino
193 Participants
n=5 Participants
191 Participants
n=7 Participants
384 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Child in caregiver-child pair · Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · Black or African American
189 Participants
n=5 Participants
190 Participants
n=7 Participants
379 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · White
4 Participants
n=5 Participants
4 Participants
n=7 Participants
8 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · More than one race
2 Participants
n=5 Participants
5 Participants
n=7 Participants
7 Participants
n=5 Participants
Race (NIH/OMB)
Child in caregiver-child pair · Unknown or Not Reported
4 Participants
n=5 Participants
0 Participants
n=7 Participants
4 Participants
n=5 Participants
Region of Enrollment
United States
199 Participants
n=5 Participants
199 Participants
n=7 Participants
398 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, 3, 6, 9 and 12 months

Population: Participants analyzed represent children with asthma enrolled in the protocol as caregiver-child pairs. Number analyzed per row vary since some families were unable to be contacted for specific assessment time points, but were able to be contacted for future assessments.

The Test for Respiratory and Asthma Control in Kids test is an assessment tool consisting of 5 questions posed to caregivers and designed to assess respiratory and asthma control in patients between 12 months and 5 years. It addresses risk and impairment domains outlined in the Asthma Guidelines and is meant to be interpreted by medical professionals. A total score is calculated from 0-100 with scores less than 80 indicating the child's asthma may not be under control and scores of 80 or more indicating that a child's asthma seems to be under control.

Outcome measures

Outcome measures
Measure
Home Based Asthma Education
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Asthma Control as Determined by Test for Respiratory and Asthma Control in Kids Assessment Tool
Baseline
70 score on a scale
Interval 50.0 to 80.0
75 score on a scale
Interval 55.0 to 85.0
Asthma Control as Determined by Test for Respiratory and Asthma Control in Kids Assessment Tool
3 months
85 score on a scale
Interval 70.0 to 95.0
80 score on a scale
Interval 60.0 to 90.0
Asthma Control as Determined by Test for Respiratory and Asthma Control in Kids Assessment Tool
6 months
85 score on a scale
Interval 75.0 to 95.0
85 score on a scale
Interval 70.0 to 95.0
Asthma Control as Determined by Test for Respiratory and Asthma Control in Kids Assessment Tool
9 months
85 score on a scale
Interval 65.0 to 95.0
85 score on a scale
Interval 75.0 to 95.0
Asthma Control as Determined by Test for Respiratory and Asthma Control in Kids Assessment Tool
12 months
85 score on a scale
Interval 70.0 to 95.0
85 score on a scale
Interval 75.0 to 95.0

SECONDARY outcome

Timeframe: Baseline, 3, 6, 9 and 12 months

Population: Participants analyzed represent children with asthma enrolled in the protocol as caregiver-child pairs. Number analyzed per row vary since some families were unable to be contacted for specific assessment time points, but were able to be contacted for future assessments.

Aggregate number of ED visits for asthma in past 90 days for all participants.

Outcome measures

Outcome measures
Measure
Home Based Asthma Education
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Total Number of Emergency Department (ED) Visits [Child]
Baseline
65 ED visits
50 ED visits
Total Number of Emergency Department (ED) Visits [Child]
3 months
34 ED visits
42 ED visits
Total Number of Emergency Department (ED) Visits [Child]
6 months
28 ED visits
32 ED visits
Total Number of Emergency Department (ED) Visits [Child]
9 months
37 ED visits
38 ED visits
Total Number of Emergency Department (ED) Visits [Child]
12 months
31 ED visits
35 ED visits

SECONDARY outcome

Timeframe: Baseline and 12 months

Population: Participants analyzed represent children with asthma enrolled in the protocol as caregiver-child pairs. Number analyzed per row vary since some families were unable to be contacted for specific assessment time points, but were able to be contacted for future assessments.

Aggregate number of hospitalizations due to asthma 12 months before randomization vs after randomization for all participants.

Outcome measures

Outcome measures
Measure
Home Based Asthma Education
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control
n=199 Participants
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Total Number of Hospitalizations [Child]
Baseline
6 asthma related hospitalizations
10 asthma related hospitalizations
Total Number of Hospitalizations [Child]
12 months
7 asthma related hospitalizations
24 asthma related hospitalizations

Adverse Events

Home Based Asthma Education

Serious events: 8 serious events
Other events: 2 other events
Deaths: 0 deaths

Control

Serious events: 16 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Home Based Asthma Education
n=398 participants at risk
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control
n=398 participants at risk
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Respiratory, thoracic and mediastinal disorders
Hospitalization due to asthma [child]
3.0%
6/199 • Number of events 9 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.
7.0%
14/199 • Number of events 24 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.
Blood and lymphatic system disorders
Non asthma related hospitalization [child]
0.00%
0/199 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.
0.50%
1/199 • Number of events 1 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.
Respiratory, thoracic and mediastinal disorders
Hospitalization due to asthma [consented caregiver]
1.0%
2/199 • Number of events 2 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.
1.0%
2/199 • Number of events 2 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.

Other adverse events

Other adverse events
Measure
Home Based Asthma Education
n=398 participants at risk
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. For those randomly assigned to the Home Based Asthma Education Arm- the consented caregiver received 4 home based and 3 phone based asthma education sessions with a community asthma outreach worker. Due to age of child, primary asthma management is provided by the caregiver, so intervention was delivered directly to caregiver.
Control
n=398 participants at risk
This arm consists of caregiver and child pairs. Caregiver is consented and is asked questions relating to the child's health due to young age of child. Caregiver is not provided a control arm specific intervention.
Social circumstances
Psychosocial Event [consented caregiver]
1.0%
2/199 • Number of events 2 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.
0.00%
0/199 • 12 months.
Reportable Adverse Events included: Deaths of child or consented caregiver, Asthma related hospitalization for child or consented caregiver, formal complaint about study, any psychosocial adverse event related to the study intervention, or any other potential adverse event as identified by Principal Investigator. Note: 199 child/consented caregiver pairs were enrolled making a total of 398 per arm assessed for adverse events.

Additional Information

Dr. Michelle Eakin

Johns Hopkins School of Medicine

Phone: 410-550-0487

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place